Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000921895-19-000811
Filing Date
2019-03-18
Accepted
2019-03-18 20:51:09
Documents
1
Period of Report
2019-03-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form411577bal_03182019.html 4  
1 OWNERSHIP DOCUMENT form411577bal_03182019.xml 4 4097
  Complete submission text file 0000921895-19-000811.txt   5686
Mailing Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054
Business Address
Balkema Gary S. (Reporting) CIK: 0001497486 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36351 | Film No.: 19689979

Mailing Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054
Business Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054 (713) 842-1249
PLx Pharma Inc. (Issuer) CIK: 0001497504 (see all company filings)

EIN.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations